Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges. | Front Pharmacol | 2023 | 37153761 | PubTator, text mining | PubMed |
Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment. | Front Immunol | 2023 | 37153569 | PubTator, text mining | PubMed |
| The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review. | Ther Adv Med Oncol | 2023 | 37152424 | PubTator, text mining | PubMed |
| Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells. | Front Oncol | 2023 | 37152024 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer. | Medicine (Baltimore) | 2023 | 37145007 | PubTator, text mining | PubMed |
| Transcriptomic analysis of B cells suggests that CD70 and LY9 may be novel features in patients with systemic lupus erythematosus. | Heliyon | 2023 | 37144201 | PubTator, text mining | PubMed |
| CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease. | Clin Transl Immunology | 2023 | 37144041 | PubTator, text mining | PubMed |
| Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2023 | 37143720 | PubTator, text mining | PubMed |
| Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion. | Front Immunol | 2023 | 37143656 | PubTator, text mining | PubMed |
| What is new in cancer-associated fibroblast biomarkers? | Cell Commun Signal | 2023 | 37143134 | PubTator, text mining | PubMed |
| A mammalian lung's immune system minimizes tissue damage by initiating five major sequential phases of defense. | Clin Exp Med | 2023 | 37142799 | PubTator, text mining | PubMed |
| High Expression of SMO and GLI1 Genes with Poor Prognosis in Malignant Mesothelioma. | Biomed Res Int | 2023 | 37139482 | PubTator, text mining | PubMed |
| Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer. | Oncoimmunology | 2023 | 37139184 | PubTator, text mining | PubMed |
| Interrogating the CD27:CD70 axis in αCD40-dependent control of pancreatic adenocarcinoma. | Front Cell Dev Biol | 2023 | 37123403 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | 37123057 | PubTator, text mining | PubMed |
| ZAP70 interaction with 13 mRNAs as a potential immunotherapeutic target for endometrial cancer. | Oncol Lett | 2023 | 37123018 | PubTator, text mining | PubMed |
| Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma. | Front Immunol | 2023 | 37122750 | PubTator, text mining | PubMed |
| Multi-targeted immunotherapeutics to treat B cell malignancies. | J Control Release | 2023 | 37121515 | PubTator, text mining | PubMed |
| Spurious intragenic transcription is a feature of mammalian cellular senescence and tissue aging. | Nat Aging | 2023 | 37117791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=37